The company is recalling eight lots of its 150 mg ranitidine syrup to the consumer level after it found trace amounts of N-nitrosodimethylamine in the heartburn medication. It is the same carcinogen that prompted recalls from several other drugmakers.
The syrup was manufactured by Lannett Company and repackaged by American Health Packaging. It was distributed nationwide to wholesalers for use in hospitals.
American Health Packaging has not received any reports of adverse events related to the recall. The company told distributors to immediately discontinue distribution of the affected lots and to notify subaccounts.
Read the full news release here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
